Affiliation:
1. Russian Research Anti-Plague Institute “Microbe”
Abstract
The aim of the work was to evaluate the efficiency of using the “Fhileas 75” hydrogen peroxide vapor generator for decontaminating the air ducts of the individually ventilated system, “Bio A.S.”, for housing of infected animals.Materials and methods. The hydrogen peroxide vapor generator “Fhileas 75” (France), a disinfectant manufactured by “FHILEASAFE” (7 % hydrogen peroxide solution and 0.15 % peracetic acid solution), separately ventilated system “Bio A.S.” (Germany) for the infected animal housing were applied in the work. Serratia marcescens 9 was used as test-culture.Results and discussion. The efficiency of using the hydrogen peroxide vapor generator “Fhileas 75” for decontamination of air ducts and internal surfaces of the rack of the individually ventilated system “Bio A.S.” on the test-culture S. marcescens 9 at 1·106 mc/ml concentration has been established (operation parameters of the individually ventilated system unit are as follows: air exchange rate – 60 changes per hour, air flow volume – 28 m3/hour, number of disinfection cycles – 5, disinfectant spraying time – 97 min, exposure time – 24 hours).
Publisher
Russian Research Anti-Plague Institute Microbe
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Epidemiology
Reference10 articles.
1. Tyurin E.A., Khramov M.V., Dyatlov I.A. [Analysis of implementation of the requirements for provision of biological safety at a potentially hazardous facility]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2018; (2):95–100. DOI: 10.21055/0370-1069-2018-2-95-100.
2. Lyapin M.N. [Concerning hazard assessment technologies when working with pathogenic biological agents]. Infektsiya i Immunitet [Infection and Immunity]. 2017; (S):1059.
3. Malyukova T.A., Boiko A.V., PaninYu.A., Bezsmertny V.E., Kutyrev V.V. [The likelihood of realization of biorisks when working with PBA of I–II groups]. Epidemiologiya i Infektsionnye Bolezni [Epidemiology and Infectious Diseases]. 2016; 21(3):136–45. DOI: 10.18821/1560-9529-2016-21-3-136-145.
4. Boles K.S., Kannan K., Gill J., Felderman M., Gouvis H., Hubby B., Kamrud K.I., Venter J.C., Gibson D.G. Digital-tobiological converter for on-demand production of biologics. Nat. Biotechnol. 2017; 35(7):672–5. DOI: 10.1038/nbt.3859.
5. Trashchenko D., Kovaleva M. [Individually ventilated cages – extra financial investments or optimal protection of personnel and laboratory animals?] Mezhdunarodny Vestnik Veterinarii [International Veterinary Bulletin]. 2014; (1):100–3.